Communication from BPHC announcing new award terms
- Details
- Published: Tuesday, 24 June 2025 12:07
- Written by 340B Editor
Communication from BPHC announcing new award terms requiring HRSA-funded health centers to provide insulin and injectable epinephrine to low-income patients at or below the price paid by the center through the 340B Drug Pricing Program. Health centers are receiving new Notice of Award letters, including the following terms: